homocysteine has been researched along with pentosidine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (57.14) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Busch, M; Franke, S; Kientsch-Engel, R; Müller, A; Sommer, M; Stein, G | 1 |
| Braun, A; Busch, M; Fleck, C; Franke, S; Müller, A; Müller, UA; Schiel, R; Stein, G | 1 |
| Hishida, A; Kato, A; Odamaki, M | 1 |
| Busch, M; Franke, C; Franke, S; Klemm, A; Lang, D; Müller, A; Passlick-Deetjen, J; Stein, G | 1 |
| Fujii, K; Saito, M; Soshi, S; Tanaka, T | 1 |
| Baragetti, I; Buccianti, G; Catapano, AL; Furiani, S; Galli, F; Maggi, FM; Raselli, S; Vettoretti, S | 1 |
| Bárány, P; Heimbürger, O; Jogestrand, T; Lindholm, B; Maruyama, Y; Qureshi, AR; Stenvinkel, P; Suliman, ME | 1 |
| Takeuchi, Y | 1 |
| do Nascimento, MM; Hayashi, SY; Lindholm, B; Manfro, RC; Pachaly, MA; Riella, MC; Stenvinkel, P; Suliman, ME | 1 |
| Saito, M | 3 |
| Higuchi, T; Kuroda, T; Saito, M; Shiraki, M; Shiraki, Y; Tanaka, S | 1 |
| Marumo, K; Saito, M | 1 |
| Suzuki, A | 1 |
| Goto, M; Iwaki-Egawa, S; Watanabe, Y | 1 |
| Kuroda, T; Saito, M; Shiraki, M; Shiraki, Y; Tanaka, S | 1 |
| Yamauchi, M | 1 |
| Hatakeyama, Y; Kasukawa, Y; Miyakoshi, N; Miyamoto, S; Narita, Y; Sasaki, K; Senma, S; Shimada, Y; Tsuchie, H | 1 |
| Abe, K; Aoki, Y; Eguchi, Y; Fujimoto, K; Furuya, T; Inage, K; Kanamoto, H; Koda, M; Norimoto, M; Ohtori, S; Orita, S; Suzuki, M; Takahashi, K; Toyoguchi, T; Umimura, T; Yamauchi, K | 1 |
| Saito, M; Shiraki, M; Taguchi, A | 1 |
7 review(s) available for homocysteine and pentosidine
| Article | Year |
|---|---|
[Assessment of bone quality with metabolic bone markers].
Topics: Alkaline Phosphatase; Amino Acids; Arginine; Biomarkers; Bone and Bones; Bone Resorption; Collagen Type I; Forecasting; Fractures, Bone; Homocysteine; Humans; Lysine; Osteocalcin; Osteogenesis; Peptides; Tensile Strength | 2007 |
[Biochemical markers of bone turnover. New aspect. Bone collagen metabolism: new biological markers for estimation of bone quality].
Topics: Arginine; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Collagen; Glycation End Products, Advanced; Homocysteine; Humans; Lysine; Osteoporosis; Oxidative Stress | 2009 |
[Poor bone quality in diabetes and arterioscelerosis].
Topics: Animals; Arginine; Arteriosclerosis; Biomarkers; Bone Density; Collagen; Diabetes Complications; Diabetes Mellitus; Fractures, Bone; Glycation End Products, Advanced; Homocysteine; Humans; Lysine; Osteoporosis; Risk | 2009 |
[Bone quality markers: pentosidine, homocysteine, and MTHFR polymorphism].
Topics: Arginine; Biomarkers; Female; Homocysteine; Humans; Lysine; Methylenetetrahydrofolate Reductase (NADPH2); Osteoporosis; Polymorphism, Genetic | 2009 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone quality in chronic kidney disease : enzymatic and non-enzymatic glycation or oxidation induced cross-links in bone].
Topics: Animals; Arginine; Bone and Bones; Bone Diseases, Metabolic; Chronic Disease; Collagen; Fractures, Bone; Glycation End Products, Advanced; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Lysine; Osteoporosis; Oxidative Stress; Risk | 2010 |
[Is bone biopsy necessary for the diagnosis of metabolic bone diseases? Non- invasive assessment of bone turn over markers could define the cause of metabolic bone diseases].
Topics: Acid Phosphatase; Alkaline Phosphatase; Arginine; Biomarkers; Biopsy; Bone and Bones; Bone Diseases, Metabolic; Collagen Type I; Diagnosis, Differential; Homocysteine; Humans; Isoenzymes; Lysine; Osteoporosis; Peptide Fragments; Peptides; Procollagen; Tartrate-Resistant Acid Phosphatase | 2011 |
[The assessment of bone quality in lifestyle-related diseases].
Topics: Arginine; Biomarkers; Bone and Bones; Bone Remodeling; Collagen; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Lysine; Osteoporosis; Pulmonary Disease, Chronic Obstructive; Renal Insufficiency, Chronic; Risk; Tomography, X-Ray Computed | 2016 |
1 trial(s) available for homocysteine and pentosidine
| Article | Year |
|---|---|
Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites.
Topics: Arginine; Cross-Over Studies; Cystathionine; Enzyme-Linked Immunosorbent Assay; Female; Fluorescence; Glycation End Products, Advanced; Homocysteine; Humans; Kidneys, Artificial; Lysine; Male; Membranes, Artificial; Middle Aged; Polymers; Prospective Studies; Renal Dialysis; Sarcosine; Sulfones | 2004 |
13 other study(ies) available for homocysteine and pentosidine
| Article | Year |
|---|---|
Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
Topics: Adult; Arginine; Coronary Disease; Cystathionine; Female; Glycation End Products, Advanced; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Logistic Models; Lysine; Male; Methylmalonic Acid; Middle Aged; Risk Factors | 2003 |
Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Transplantation; Lysine; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking | 2003 |
Association between blood indoxyl sulfate and carbonyl stress marker in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Arginine; Biomarkers; Blood Proteins; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Indican; Lysine; Male; Middle Aged; Regression Analysis; Renal Dialysis; Time Factors | 2003 |
Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture.
Topics: Aged; Aged, 80 and over; Arginine; Bone Density; Calcification, Physiologic; Collagen; Female; Femoral Neck Fractures; Femur Neck; Glycosylation; Homocysteine; Humans; Hydroxylation; Lysine; Protein Processing, Post-Translational | 2006 |
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study.
Topics: Aged; Analysis of Variance; Antioxidants; Arginine; Brachial Artery; Endothelium, Vascular; Female; Glycation End Products, Advanced; Homocysteine; Humans; Linear Models; Lipoproteins, LDL; Lysine; Male; Membranes, Artificial; Middle Aged; Oxidative Stress; Pilot Projects; Renal Dialysis; Vasodilation; Vitamin E | 2006 |
Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
Topics: Adult; Arginine; Atherosclerosis; Biomarkers; Carotid Artery, Common; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Organophosphates; Prognosis; Prospective Studies; Renal Dialysis; Severity of Illness Index; Time Factors; Tunica Intima; Ultrasonography | 2006 |
Interleukin-6 is a better predictor of mortality as compared to C-reactive protein, homocysteine, pentosidine and advanced oxidation protein products in hemodialysis patients.
Topics: Adult; Arginine; C-Reactive Protein; Female; Glycation End Products, Advanced; Homocysteine; Humans; Interleukin-6; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Oxidation-Reduction; Prognosis; Proteins; Renal Dialysis; Survival Rate | 2008 |
Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment.
Topics: Aged; Arginine; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Bone; Homocysteine; Humans; Lysine; Middle Aged; Osteoporosis; Proportional Hazards Models | 2011 |
Ageing in Werner syndrome.
Topics: Adult; Aged, 80 and over; Aging; Arginine; Female; Health; Homocysteine; Humans; Lysine; Male; Middle Aged; Werner Syndrome | 2012 |
Plasma level of homocysteine associated with severe vertebral fracture in postmenopausal women.
Topics: Aged; Arginine; Body Mass Index; Bone Density; Cohort Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Japan; Logistic Models; Lysine; Middle Aged; Odds Ratio; Osteoporosis, Postmenopausal; Prevalence; Regression Analysis; Reproducibility of Results; Risk Factors; Spinal Fractures | 2013 |
Factors related to curved femur in elderly Japanese women.
Topics: Aged; Aged, 80 and over; Arginine; Bone Density; Calcium; Female; Femoral Fractures; Femur; Homocysteine; Humans; Japan; Lumbar Vertebrae; Lysine; Middle Aged; Multivariate Analysis; Odds Ratio; Parathyroid Hormone; Regression Analysis; Vitamin D; Vitamin D Deficiency | 2016 |
Pentosidine concentration is associated with degenerative lumbar scoliosis in older women: preliminary results.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Arginine; Biomarkers; Calcifediol; Calcitriol; Case-Control Studies; Female; Femur; Homocysteine; Humans; Kyphosis; Lordosis; Lumbar Vertebrae; Lysine; Middle Aged; Sarcopenia; Scoliosis; Spine | 2018 |
Association of pentosidine and homocysteine levels with number of teeth present in Japanese postmenopausal women.
Topics: Aged; Arginine; Bone Density; Female; Homocysteine; Humans; Japan; Lysine; Postmenopause; Tooth Loss | 2022 |